(NASDAQ: PDSB) Pds Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31%.
Pds Biotechnology's earnings in 2026 is -$33,671,961.On average, 5 Wall Street analysts forecast PDSB's earnings for 2026 to be -$25,690,844, with the lowest PDSB earnings forecast at -$25,231,879, and the highest PDSB earnings forecast at -$25,858,758. On average, 5 Wall Street analysts forecast PDSB's earnings for 2027 to be -$21,313,886, with the lowest PDSB earnings forecast at -$21,940,764, and the highest PDSB earnings forecast at -$19,394,069.
In 2028, PDSB is forecast to generate -$19,601,163 in earnings, with the lowest earnings forecast at -$23,586,322 and the highest earnings forecast at -$14,692,476.